Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

FCGR2B 293T Cell Overexpression Lysate (Denatured), Abnova

Catalog No. 89008959 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-008-959 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-008-959 Supplier Abnova Corporation Supplier No. H00002213T01
Add to Cart
Add to Cart

Cell transient overexpression lysate for FCGR2B

  • Fc fragment of IgG, low affinity IIb, receptor (CD32)
  • Transfected cell line: 293T
  • Plasmid: pCMV-FCGR2B full-length
  • Host: Human
  • Theoretical molecular weight: 34.21kDa
  • Storage buffer: 1x sample buffer (50mM Tris-HCl, 2% SDS, 10% glycerol, 300mM 2-mercaptoethanol, 0.01% bromophenol blue)

Western Blotting

Specifications

Cell Line 293T
For Use With (Application) Western Blot
Description FCGR2B 293T Cell Transient Overexpression Lysate(Denatured)
Gene Accession No. NM_004001
Molecular Weight (g/mol) 34.21
pH Range 6.8
Plasmid pCMV-FCGR2B full-length
Quality Control Testing Transient overexpression cell Lysate was tested with Anti-FCGR2B antibody (H00002213-B01) by western blotting
Quantity 100 μL
Storage Buffer 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
Host Species Human
Content And Storage Store at -80°C. Aliquot to avoid repeated freezing and thawing.
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.